Background. New tools to better monitor dynamics of human immunodeficiency virus (HIV) transmission are needed.
develop surveillance tools with which the dynamics of HIV transmission can be better understood.
Several laboratory assays to detect recent or early HIV-1 infection have been developed over the past 10 years for surveillance purposes. In 1998, Janssen et al. [1] described a 2-step algorithm to detect recent seroconversion called "serologic testing algorithm for recent HIV-1 seroconversion." This algorithm used a lesssensitive standard commercial EIA: patients who scored positive for HIV antibodies on a current-generation high-sensitivity assay but negative on a low-sensitivity test were considered to have been recently infected. On the basis of the same principle, an assay was developed by the French National Reference Center (NRC) to discriminate between recent and established HIV infection [2] .
In addition to the monitoring of recent infections (RIs), the evolving genetic diversity of HIV strains also requires close monitoring because of its potential to affect diagnosis, biological follow-up, and therapy. An increasing diversity of the viruses circulating and substantially more non-B strains among new HIV diagnoses have been reported in most western European countries with large immigrant communities [3] [4] [5] [6] [7] [8] . Therefore, we implemented a program of surveillance for RIs and HIV strains among persons with new HIV diagnoses in France in 2003 [9] . This dual monitoring, termed "virological surveillance" (VS), used dried serum spots (DSS) obtained at the same time as HIV diagnosis and notification. Here, we report the results of the first 2 years of surveillance, from 1 January 2003 to March 2005.
MATERIALS AND METHODS

Case Reporting of HIV
Mandatory anonymous HIV case reporting was implemented in France in 2003, and the procedures have been described elsewhere [9] . 
Virological Surveillance
The surveillance used DSS to determine both the type, group, and subtype of HIV of each new HIV diagnosis and whether the HIV infection was recent (!6 months) or not. For each case, the laboratory is asked to send DSS from the stored serum sample obtained for original diagnosis to the NRC by mail [9] . Results from the NRC are then linked to the epidemiological data in the HIV national database using the patient's anonymous code. Although HIV notification is mandatory, VS is based on volunteer participation by both microbiologists and patients. The patient's consent for VS is obtained by the reporting clinician through the HIV notification form.
Laboratory Methods
Immunoassay to identify RIs (EIA-RI). The characteristics and properties of EIA-RI have been described elsewhere [2] . Using DSS, the EIA-RI is able to identify RIs (!6 months) among all infected patients (without AIDS) with a sensitivity of 87% and a specificity of 98%. The EIA-RI is less specific for patients with AIDS; therefore, patients known to have AIDS (information collected from the HIV reporting form) are classified as having established infection whatever the result of the EIA-RI. Identification of type, group, and subtype of HIV. A novel ELISA format has been developed and applied to serum eluted from DSS [10] . Serological discrimination is based on antibody binding to either the immunodominant epitope of gp41 or the V3 domain of gp120 of various types, groups, and subtypes. The assay allows classification of samples as HIV-1 or HIV-2, as HIV-1 group M or group O, and among group M as B or non-B. However, the serotyping approach has 2 limitations. First, it can be interpreted only if infected patients have developed enough antibodies when they are tested-as a consequence, most serotyping failures are for patients with RI. Second, serotyping cannot differentiate among the major non-B subtypes (A, C, F, G, and CRF02_AG) [11] . Therefore, a subsample was genotyped by sequencing a 415-bp fragment of the gp41 region obtained by reverse-transcription polymerase chain reaction (RT-PCR) of RNA extracted from DSS [12] . The subsample used for genotyping included all DSS that were collected before 20 January 2005 for which serotyping provided a nontypeable result.
Statistical Analysis
Two outcomes were studied separately: (1) RI among new HIV-1 diagnoses for which a DSS was available (among 5764 individuals) and (2) infection with a non-B subtypes among new HIV-1 diagnoses subtyped as B or non-B (among 5160 individuals). Proportions were compared using standard x 2 tests. Variables that were significant in univariate analysis were entered into a multiple logistic regression model (using backward elimination) to identify factors independently associated to each outcome studied (using a global test).
For each final model, goodness of fit was assessed by the Hosmer-Lemeshow test. All analyses were conducted with SAS software (version 08; SAS Institute), and statistical significance was set at . P ! .05 (table  1) . Individuals from sub-Saharan countries accounted for one third of all cases (33%;
RESULTS
Description
). The most frequent origins n p 2619 were Cameroon and Cô te d'Ivoire (46%; ). Results of n p 1213 test of RI were not available for 2138 (27%) of new HIV diagnoses, because the laboratory did not submit DSS to the NRC (23%) or the patient refused to participate (4%). Those cases were excluded from further analysis. Among these excluded cases, the proportion of men who have sex with men (MSM; 18%) and those of French nationality (40%) was lower, whereas the proportions of unknown mode of transmission (24%) and unknown nationality (24%) were higher than those among included cases.
Infections with rare variants (HIV-2 and HIV-1 group O). The proportion of HIV-2 infections was 1.9% (95% confidence interval [CI], 1.5%-2.2%), of which 1.6% ( ) were HIVn p 93 2 only and 0.3% ( ) were probable dual infections. Pern p 18 sons infected with HIV-2 ( ) were mostly born in West n p 111 Africa (65%; ), mostly Côte d'Ivoire and Mali. However, n p 72 there were 5 French citizens (born in France) infected sexually with HIV-2, 1 of whom reported being an MSM.
Eleven patients (0.2%) were infected with HIV-1 group O, and they were mainly born in sub-Saharan Africa (8 in Cameroon and 1 in Chad). The 2 other cases were French citizens and had probably been infected through heterosexual intercourse. Of these 11 patients, 2 had dual M/O infection, described in detail elsewhere [12] .
RIs among new HIV-1 diagnoses. ) and in persons n p 581 originating from France (36%;
) than in those origin p 914 nating from sub-Saharan Africa (10%;
). The proporn p 201 tion of RIs among heterosexual persons varied according to citizenship: 29% among the French versus 10% among Africans ( ). RI was also more frequent in patients infected with P ! .001 subtype B virus (21%;
). However, a large proportion n p 560 of samples from patients (39%; ) with RI were not n p 554 typeable because of the limitations of the serotyping assay during early infection. In multiple logistic regression analysis, RI was independently associated with being MSM, being !30 years old, having been screened for HIV after exposure, living in the Paris area, being of French nationality, and receiving a diagnosis during the first half of 2003 (table 2) .
Non-B subtypes among new HIV-1 diagnoses. ). The proportion of sub-Saharan African and n p 469
French heterosexual persons with non-B subtypes was 81% ( ) and 34% ( ), respectively. n p 1295 n p 298 In multiple logistic regression analysis, being infected with non-B subtype virus was independently associated with being African (male or female), being !30 years old, being heterosexual, or living in the Paris area (table 3) .
Genotyping was performed on 268 DSS. Most of them were from cases of RI (83%;
). RT-PCR products were obn p 222 tained for 150 cases (56%). The proportion of B subtype in- fection was high (75%; ). However, 11 (13%) of 85 n p 113 MSM were found infected with non-B genotypes, and 1 (11%) of 9 African citizens was infected by B variant. The distribution of the 37 non-B genotypes were as follows:
), and U ( ). n p 2 n p 4 We performed an additional phylogenetic analysis to identify possible clusters of patients exposed to identical strains. Eight clusters of 2-4 cases were observed: 5 of clade B, 2 of clade CRF02_AG, and 1 of clade G ( figure 1) . Three of these clusters fitted with the epidemiological data: 1 B cluster included 4 MSM with new diagnoses reported in Paris, 1 B cluster involved 2 heterosexually infected women who received their diagnoses in an overseas department, and 1 CRF02_AG cluster included 2 French MSM with new diagnoses reported in Paris.
DISCUSSION
Here, we report data from the first 2 years of a national longterm monitoring of HIV infection by combining the surveillance of recent HIV infection and the typing of circulating HIV strains with HIV case reporting. To our knowledge, this is the first report of such an integrated system at a national level. This implementation has only been feasible by use of assays adapted to test serum samples collected on filter paper.
We estimated that one quarter of patients with new diagnoses had been infected within the 6 months preceding HIV diagnosis. This is quite similar to results reported recently in 2 more restricted studies of new HIV diagnoses in Austria and Australia [16, 17] .
The proportion of RIs among new HIV diagnoses at a given time reflects both HIV incidence and the testing pattern. If a population subgroup is tested more frequently than others, patients from this subgroup are more likely than others to be diagnosed during the early stage of infection. This is particularly true for MSM, who seek HIV testing more frequently than heterosexual men in France [18, 19] . Therefore, comparison of the proportion of RIs by transmission group must take the testing pattern of each group into account table 4. The proportion of RIs should also be interpreted with caution for 2 other reasons. First, the EIA-RI was developed to detect several subtypes. Nevertheless, dedicated studies are required to evaluate the performance of this assay with non-B samples, considering the high proportion of such subtypes among new HIV-1 diagnoses in France. Second, of all the new HIV diagnoses, 27% were not tested by EIA-RI because of a refusal to participate by the microbiologist or the patient. This could lead to an overestimate of the overall proportion of RI because of the characteristics of persons excluded from the analysis (e.g., fewer MSM).
However, although the high proportion of RIs among MSM (46%) might reflect testing patterns, there has been strong evidence of HIV transmission among MSM in France during recent years. Other epidemiological data concerning MSM corroborate this finding. For instance, behavioral surveys of MSM readers of gay magazines in France have shown a significant increase in the proportion of unprotected anal intercourse (from 19% in 1997 to 33% in 2004) [18] . Furthermore, the outbreak of syphilis in 2000 and the emergence of rectal lymphogranulomatosis in 2004 occurred mostly among MSM who were also infected with HIV [20, 21] . These observations suggest that MSM have been engaging in high-risk sexual behaviors.
French citizens were more likely to be diagnosed during the RI period than persons of African origin. Data on the testing behavior of Africans living in France are scarce, but it is likely that they are less frequently tested for HIV than are French citizens and they also could have arrived in France after infection. Despite this, the proportion of new infections (within the Figure 1 . Phylogenetic tree based on 320 unambiguously aligned nucleotides from the gp41 region. For clarity, only 93 of 150 sequences obtained from the dried serum spots are shown, of which the 23 sequences of 8 identified clusters are boxed. Arrows show the 3 clusters that fitted with the epidemiological data, as described in the text. Also, for clarity, the reference sequences (imported from the HIV sequence database) are only from subtypes B (B.US.JRFL, B.US.RF, and B.WEAU160), G (G.92NG083, G.HH8793, and G.SE6165), and CRF02_AG (02_DJ264, 02_IBNG, 02_MP807), with group O (ANT70) as an outgroup. Nucleotide sequences were assembled using BioEdit software (version 5.0.9) and were aligned using Clustal W software [13] . Phylogenetic analysis and tree reconstructions were performed by the neighbor-joining method, using MEGA software (version 3.1) [14] . The distance matrix was calculated with the 2-parameter Kimura algorithm (transition:transversion ratio, 2.0) [15. Approximate confidence limits for individual branches were assigned by bootstrap resampling with 500 replicates. The bootstrap values of the 3 major clades and for each of the 8 clusters are in bold type. preceding 6 months) among Africans in France was not negligible (10%). This suggests continued transmission that needs to be addressed through targeted prevention.
The proportion of RIs was greater among residents of the Paris area than among residents of other regions. This may be due to differences in high-risk behavior (although there is no evidence of such from behavioral surveys of MSM). More probably, it is the result of more frequent screening in the Paris area, which is consistent with the higher HIV testing rate (108 HIV tests/1000 inhabitants in Paris vs. 76 HIV tests/1000 inhabitants elsewhere in 2004) [22] . Non-B subtypes were also more frequent in the Paris area, where there is more oppor- tunity for diffusion of non-B strain probably because, at least in part, 60% of immigrants from sub-Saharan Africa live in this region [23] . The proportion of RIs was stable over time, except that it was high during first half of 2003. This finding is difficult to interpret. The HIV case reporting and the VS were set up during the first half of 2003, with a large information campaign aimed at all registered doctors and laboratories. It is therefore possible that doctors were more inclined to offer screening at an earlier stage (i.e., as soon as patients showed any clinical symptoms of a primary infection). We conducted a complementary analysis after the exclusion of all cases diagnosed during the first half of the year, and we found no association between the time of diagnosis and RI; the results were similar to those presented in tables 2 and 3 (data not shown).
In France, as elsewhere in Western Europe, the HIV-1 epidemic has historically been dominated by strains of subtype B [4] . Our results indicate a higher proportion of non-B subtypes than was previously observed in France (15% in 1996-1998 and 33% in 2001) that is probably a consequence of immigration from Africa [3, 5, 23] . However, the proportion of subtype B infections among African persons living in France is substantial (19%) and contrasts with the finding that subtype B is very rare in sub-Saharan Africa table 5on [24] [25] [26] . In addition, the proportion of infected French citizens with non-B subtypes (22%) was high, whether they were exposed through heterosexual (34%) or homosexual (13%) intercourse. There is, therefore, evidence of transmission of non-B subtypes within the indigenous French population living in France. The presence of non-B subtypes in MSM, including those recently infected (17%), further suggests increasing genetic diversity of HIV strains that are transmitted within the homosexual community in France. Both the presence of non-B infections in French citizens and subtype B infections in Africans suggest bridges between 2 initially distinct HIV epidemics. Other European countries, in particular the United Kingdom, are faced with similar trends associated with an immigrant populations from eastern subSaharan Africa [6] [7] [8] . The propagation of non-B virus strains in the United Kingdom has been documented by a study conducted in London among 344 persons with new HIV diagnoses, 23% of all non-B infections were believed to have been acquired in the United Kingdom [6] .
One limitation of our analysis of HIV subtypes is the low sensitivity of the serotyping assay during the early weeks of seroconversion. Nonserotypeable samples made up 39% of those from recently infected patients based on the EIA-RI results but only 2% of those from patients with long-lasting infection. This low sensitivity is because antibodies to V3 take a few weeks or months after seroconversion to reach a level sufficient to be detectable in the serotyping assay [27, 28] . One hundred fifty nonserotypeable samples were genotyped, and the proportion of B viruses (75%) in this subsample was consistent with the higher proportion of persons infected by B serotypes among persons with RI. On the basis of our experience, failure to yield a result in 118 samples could be attributed mainly to a viral load that might be !10,000 copies/mL in those samples [29] . The genotyping data confirmed both trends identified by serotyping: that of non-B infections in recently infected MSM and that of B variants in African citizens recently infected through heterosexual contact. Approximately half of the non-B samples were from patients infected with CRF02_AG variants, in accordance with data obtained from 2 different studies in France [5, 30] . Phylogenetic analysis identified a few possible clusters of patients exposed to identical strains, of which 3 fitted perfectly with the epidemiological data, including one CRF02_AG cluster in French MSM newly diagnosed in Paris.
The VS made possible the first detailed estimate of the proportion of rare variants (HIV-2 and HIV-1 group O) in a western European country. Although most of the patients infected by HIV-2 or HIV-1 group O originated from countries in African areas where these strains are endemic (western Africa and Cameroon, respectively), some French citizens (born and living in France) had been infected sexually by these rare variants. This included a few MSM infected with HIV-2. This national surveillance also allowed the first identification of dual M/O infections in Europe [12] .
We have developed a more comprehensive HIV surveillance system by combining mandatory HIV reporting with the biological identification of RI and the monitoring of viral genetic diversity. In addition, this surveillance system should be reinforced in the near future by the addition of monitoring of antiretroviral resistance.
This new system has been shown to be feasible at a national level and provides important demographic and epidemiological data on the recently infected population. Such data are useful for targeting prevention strategies. Data concerning RIs among MSM have already been used to strengthen prevention campaigns and to renew prevention message in the gay community in France (http://www.inpes.fr). In addition, this surveillance system should be reinforced in a near future by the addition of monitoring of antiretroviral resistance.
